Search for: "ALL ARTICLES OF DRUG LOCATED AT GLOBAL BIOTECHNOLOGIES INC"
Results 1 - 8
of 8
Sort by Relevance
|
Sort by Date
4 Jan 2021, 1:29 pm
All qualified applicants will receive considerat [read post]
14 Dec 2020, 10:01 am
” CSIS expert James Andrew Lewis will join Becky Burr, partner at Harris, Wiltshire & Grannis LLP, and Steve Crocker, CEO and Co-Founder of Shinkuro, Inc., to consider questions facing policymakers today on content moderation and privacy concerns and discuss what the future of internet governance should look like. [read post]
26 Oct 2020, 12:04 pm
The committee will hear testimony from Jack Dorsey, the CEO of Twitter; Sundar Pichai, the CEO of Alphabet Inc. and Mark Zuckerberg, the CEO of Facebook. [read post]
26 Nov 2013, 4:45 pm
Each program offered all of the basics including survey courses and core courses in patents, trade-marks and copyrights.[8] They also offered both theoretical and practical advanced courses in IP law as well as intensive or clinical programs that enable students to specialize in IP law. [read post]
December 29, 2009 – Environmental Law Settlements, Decisions, Regulatory Actions and Lawsuit Filings
29 Dec 2009, 5:50 pm
These were all first posted, in abbreviated form, on http://twitter.com/smtaber. [read post]
December 29, 2009 – Environmental Law Settlements, Decisions, Regulatory Actions and Lawsuit Filings
29 Dec 2009, 5:46 pm
These were all first posted, in abbreviated form, on http://twitter.com/smtaber. [read post]
13 Jun 2008, 3:40 am
: (Patent Docs), Generic drug developers will continue to take advantage of global demand for lower-priced drugs, with Teva poised to maintain lead position says Goldman Sachs analyst: (GenericsWeb), Daiichi Sankyo takeover of Ranbaxy: (Profitability through Simplicity), (Spicy IP), (GenericsWeb), Canada: Generics to penetrate 26% pharma market in Canada says RNCOS research: (GenericsWeb), Canada: Generic drug makers spreading misinformation about patent… [read post]
25 Jan 2008, 1:00 am
: (Generic Pharmaceuticals & IP),Arava (Leflunomide) - Sanofi-Aventis loses bid to dismiss Louisiana Wholsesale Drug Co's antitrust claims accusing S-A of unlawfully blocking generic competition for Arava by filing a sham Citizen Petition with the USFDA: (IP Law360),Ciprofloxacin - CIPLA issued notice by National Pharmaceutical Pricing Authority for allegedly overpricing its antibiotic Ciprofloxacin (especially of note because CIPLA is… [read post]